Neurobiological Technologies (Neurobiological Technologies) EV-to-Revenue : 0.00 (As of Jun. 06, 2024)

Neurobiological Technologies EV-to-Revenue Chart

Neurobiological Technologies Annual Data
	Trend	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09
EV-to-Revenue		Get a 7-Day Free Trial					23.71	5.82	2.80	0.66	-0.21

Neurobiological Technologies Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09
EV-to-Revenue	Get a 7-Day Free Trial															-0.80	-1.03	-0.24	-0.21	-0.07

Competitive Comparison of Neurobiological Technologies's EV-to-Revenue

For the Biotechnology subindustry, Neurobiological Technologies's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurobiological Technologies's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurobiological Technologies's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Neurobiological Technologies's EV-to-Revenue falls into.

Neurobiological Technologies EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Neurobiological Technologies's EV-to-Revenue for today is calculated as:

Neurobiological Technologies's current Enterprise Value is $0.00 Mil.
Neurobiological Technologies's Revenue for the trailing twelve months (TTM) ended in Sep. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $28.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurobiological Technologies  (OTCPK:NTII) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Neurobiological Technologies's PS Ratiofor today is calculated as:

Neurobiological Technologies's share price for today is $0.0001.
Neurobiological Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurobiological Technologies EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Neurobiological Technologies's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurobiological Technologies (Neurobiological Technologies) Business Description